Patent · US Active

Compositions against cancer antigen LIV-1 and uses thereof

US8591863B2 · kind B2 · utility

4Cited by
15References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 20, 2012
Grant dateNov 26, 2013
Priority date—
Expiry dateJul 1, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/505
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.